Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
about
Prevention by Lamivudine of hepatocellular carcinoma in patients infected with hepatitis B virusHepatitis B mother--to--child transmission.Assessment of safety/risk vs. Public health concerns: Aflatoxins and hepatocarcinoma.Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo.Glycyrrhizin inhibits the lytic pathway of complement--possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis.
P2860
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@ast
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@en
type
label
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@ast
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@en
prefLabel
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@ast
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@en
P2860
P921
P1476
Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1999.TB00676.X
P577
1999-10-01T00:00:00Z